ESTRO 2025 - Abstract Book

S2071

Clinical - Urology

ESTRO 2025

Conclusion: RETRO-DOTA-5F study showed that DIL boost in standard 5-fraction MRgART SBRT using Unity MR-Linac system is safe and effective for localized prostate cancer. However, longer follow up time is mandated for the robust evaluation.

Keywords: SBRT, DIL, MR Linac

References: 1.van As, N., et.al. (2024). Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer. The New England journal of medicine, 391(15), 1413 – 1425. 2. Dankulchai, P.(2022). Feasibility and safety of definite volumetric modulated arc therapy with simultaneous integrated boost to the dominant intraprostatic lesion in patients with unfavorable intermediate to high-risk prostate cancer.